|
CN107267546A
|
|
Polycistronic expression systems for bacterium
|
|
WO2011160062A2
|
|
Compositions and methods for treating inflammatory conditions
|
|
EP2424972A1
|
|
Cryoprotectants for freeze drying of lactic acid bacteria
|
|
EP2283830A1
|
|
Aqueous enteric capsule coating
|
|
EP2275527A1
|
|
Animal component-free culture medium for bacterial fermentation
|
|
EP2243487A1
|
|
Enteric coated formulation
|
|
EP2164512A2
|
|
Methods and compositions for treating mucositis
|
|
CN103933563A
|
|
Treatment of immune disease by mucosal delivery of antigens
|
|
WO2008071751A1
|
|
Delivery of binding molecules to induce immunomodulation
|
|
BRPI0711119A2
|
|
microbial administration of obesity-associated intestinal peptides
|
|
EP1931762A1
|
|
Use of recombinant yeast strain producing an anti -inflammatory compound in the manufacture of a medicament to treat colitis
|
|
EP1789529A2
|
|
Method to improve lactococcus preservation
|
|
US2005101005A1
|
|
Self-containing Lactococcus strain
|
